Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1634 1655 1683
This examiner grants 12% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17289889 | NUCLEIC ACID-BASED BARCODING | Non-Final OA | PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
| 17525336 | Synaptojanin 2 (SYNJ2) Variants And Uses Thereof | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 19249209 | METHOD OF IDENTIFYING A BIOLOGICALLY-ACTIVE COMPOSITION FROM A BIOFILM | Non-Final OA | QUORUM INNOVATIONS,INC. |
| 19202001 | ISOLATED POLYPEPTIDE OF THE TOXIN A AND TOXIN B PROTEINS OF C. DIFFICILE AND USES THEREOF | Non-Final OA | Valneva USA, Inc. |
| 19034863 | AAV-MEDIATED DELIVERY OF THERAPEUTIC ANTIBODIES TO THE INNER EAR | Non-Final OA | Akouos, Inc. |
| 18269634 | CLEAVAGE OF CAPTURE PROBES FOR SPATIAL ANALYSIS | Non-Final OA | 10x Genomics, Inc. |
| 18120024 | CONCATEMERIC DETECTABLE PROBES AND RELATED METHODS | Non-Final OA | 10x Genomics, Inc. |
| 18046457 | COMPOSITIONS AND METHODS FOR USE WITH FIXED SAMPLES | Non-Final OA | 10x Genomics, Inc. |
| 18021625 | PANCREATIC DUCTAL ADENOCARCINOMA SIGNATURES AND USES THEREOF | Non-Final OA | The General Hospital Corporation |
| 17616621 | CRISPR SYSTEM HIGH THROUGHPUT DIAGNOSTIC SYSTEMS AND METHODS | Non-Final OA | THE GENERAL HOSPITAL CORPORATION |
| 18606200 | CONSTRUCTS, USE AND METHODS THEREOF | Non-Final OA | SUNNYBROOK RESEARCH INSTITUTE |
| 19018613 | Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine | Non-Final OA | Mammal Labs LLC |
| 18040066 | Characterising Macrophages and Methods Thereof | Final Rejection | Agency for Science, Technology and Research |
| 17806099 | DETECTION METHOD | Final Rejection | TOPPAN Inc. |
| 18806201 | Method for Measuring Fibroblast Growth Factor-23 and Reagent Therefor | Non-Final OA | Canon Medical Diagnostics Corporation |
| 17278386 | LIGAND DETECTION BY APTAMERS WITH A BUILT-IN REPORTER | Non-Final OA | King Abdullah University of Science and Technology |
| 17172527 | METHODS AND COMPOSITIONS FOR MESSENGER RNA PURIFICATION | Non-Final OA | Translate Bio, Inc. |
| 18261537 | METHODS FOR EVALUATION OF EARLY STAGE ORAL SQUAMOUS CELL CARCINOMA | Non-Final OA | LOMA LINDA UNIVERSITY |
| 18001805 | FLUORESCENT CYTOSINE ANALOGUES AND THEIR APPLICATION IN TRANSCRIPTION AND TRANSLATION | Non-Final OA | STEALTH LABELS BIOTECH AB |
| 18010108 | BIOMARKER COMBINATIONS FOR DETERMINING AGGRESSIVE PROSTATE CANCER | Non-Final OA | MINOMIC INTERNATIONAL LTD. |
| 16022597 | METHOD OF TREATING COLORECTAL CANCER | Non-Final OA | HOSPITAL CLINIC DE BARCELONA |
| 16918958 | HIGH CAPACITY MOLECULE DETECTION | Final Rejection | Davinci Bio, Inc. |
| 11713579 | Epigenetic modification of the loci for CAMTA1 and/or FOXP3 as a marker for cancer treatment | Non-Final OA | PRECISION FOR MEDICINE GMBH |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy